Clinical Trial Update: 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 18F-AV-1451 and Florbetapir F18 PET imaging in individuals at risk for Chronic Traumatic Encephalopathy has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Encephalopathy

Drugs mentioned

• 18F-AV-1451 (flortaucipir)
• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Chronic Traumatic Encephalopathy | Phase 2 | Status: COMPLETED | Results posted: 2020-09-07